Sökning: onr:"swepub:oai:DiVA.org:uu-305538" >
Apixaban compared w...
-
Ezekowitz, Michael D.Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.;Lankenau Med Ctr, Wynnewood, PA USA.
(författare)
Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion : Rationale and design of the EMANATE trial
- Artikel/kapitelEngelska2016
Förlag, utgivningsår, omfång ...
-
Elsevier BV,2016
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-305538
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-305538URI
-
https://doi.org/10.1016/j.ahj.2016.06.008DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Background: Stroke prevention in anticoagulation-nafve patients with atrial fibrillation undergoing cardioversion has not been systematically studied.Objective: To determine outcomes in anticoagulation-naive patients (defined as those receiving an anticoagulant for <48 hours during the index episode of atrial fibrillation) scheduled for cardioversion.Methods: This is a randomized, prospective, open-label, real-world study comparing apixaban to heparin plus warfarin. Early image-guided cardioversion is encouraged. For apixaban, the usual dose is 5 mg BID with a dose reduction to 2.5 mg BID if 2 of the following are present: age >80 years, weight <60 kg, or serum creatinine >1.5 mg/dL. If cardioversion is immediate, a single starting dose of 10 mg (or 5 mg if the dose is down-titrated) of apixaban is administered. Cardioversion may be attempted up to 90 days after randomization. Patients are followed up for 30 days after cardioversion or 90 days postrandomization if cardioversion is not performed within that timeframe. Outcomes are stroke, systemic embolization, major bleeds, clinically relevant nonmajor bleeding, and death, all adjudication-blinded.Statistics: The warfarin-naive cohort from the ARISTOTLE study was considered the closest data set to the patients being recruited into this study. The predicted incidence of stroke, systemic embolism, and major bleeding within 30 days after randomization was approximately 0.75%. To adequately power for a noninferiority trial, approximately 48,000 participants would be needed, a number in excess of feasibility. The figure of 1,500 patients was considered clinically meaningful and achievable.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Pollack, Charles V.Thomas Jefferson Univ, Philadelphia, PA 19107 USA.
(författare)
-
Sanders, PaulPfizer, London, England.
(författare)
-
Halperin, Jonathan L.Icahn Sch Med Mt Sinai, New York, NY 10029 USA.
(författare)
-
Spahr, JudithLankenau Inst Med Res, Wynnewood, PA USA.
(författare)
-
Cater, NiloPfizer, New York, NY USA.
(författare)
-
Petkun, WilliamBristol Myers Squibb Inc, Princeton, NJ USA.
(författare)
-
Breazna, AndreiPfizer, New York, NY USA.
(författare)
-
Kirchhof, PaulusUniv Birmingham, SWBH UHB NHS Trusts, Inst Cardiovasc Sci, Birmingham, W Midlands, England.;Univ Hosp Munster, Dept Cardiol & Angiol, Munster, Germany.
(författare)
-
Oldgren, JonasUppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)jonaoldg
(författare)
-
Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.;Lankenau Med Ctr, Wynnewood, PA USA.Thomas Jefferson Univ, Philadelphia, PA 19107 USA.
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:American Heart Journal: Elsevier BV179, s. 59-680002-87031097-6744
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Ezekowitz, Micha ...
-
Pollack, Charles ...
-
Sanders, Paul
-
Halperin, Jonath ...
-
Spahr, Judith
-
Cater, Nilo
-
visa fler...
-
Petkun, William
-
Breazna, Andrei
-
Kirchhof, Paulus
-
Oldgren, Jonas
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
American Heart J ...
- Av lärosätet
-
Uppsala universitet